Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT
- PMID: 21431846
- PMCID: PMC3133651
- DOI: 10.1007/s00404-011-1874-1
Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT
Abstract
Purpose: Fertility preservation methods are playing an increasing role in women up to the age of 40 years because of rising survival rates in those affected by cancer. However, balanced practical recommendations concerning all relevant fertility preservation, to support doctors in counselling and treating patients, are still rare.
Methods: These recommendations were prepared by the network FertiPROTEKT ( http://www.fertiprotect.eu ), a collaboration of around 70 centres in Germany, Switzerland and Austria. The recommendations were developed by specialists in reproductive medicine, reproductive biology and oncology, which gave a comprehensive overview of all named techniques as well as their benefits and risks. Furthermore, practice-orientated recommendations for the individual use of fertility preservation methods for various indications such as breast cancer, Hodgkin's lymphoma and borderline ovarian tumours are given.
Results: Various options such as ovarian stimulation and cryopreservation of unfertilised or fertilised oocytes, cryopreservation and transplantation of ovarian tissue, GnRH-agonist administration and transposition of the ovaries can be offered. All the techniques can be performed alone or in combination within a maximum of 2 weeks with low risk and different success rates.
Conclusions: Fertility preservation in women has become an option with realistic chances to become pregnant after cytotoxic therapies. The information provided allows a well balanced and realistic counselling and treatment.
Figures


Similar articles
-
Fertility preservation in >1,000 patients: patient's characteristics, spectrum, efficacy and risks of applied preservation techniques.Arch Gynecol Obstet. 2011 Mar;283(3):651-6. doi: 10.1007/s00404-010-1772-y. Epub 2010 Dec 1. Arch Gynecol Obstet. 2011. PMID: 21120512
-
Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases-an analysis of 992 stimulations.J Assist Reprod Genet. 2018 Sep;35(9):1713-1719. doi: 10.1007/s10815-018-1227-0. Epub 2018 Jun 5. J Assist Reprod Genet. 2018. PMID: 29869766 Free PMC article.
-
Fertility preservation options in breast cancer patients.Gynecol Endocrinol. 2015;31(11):846-51. doi: 10.3109/09513590.2015.1081684. Epub 2015 Sep 15. Gynecol Endocrinol. 2015. PMID: 26370157 Review.
-
Fertility preservation in women with borderline ovarian tumours.Cancer Treat Rev. 2016 Sep;49:13-24. doi: 10.1016/j.ctrv.2016.06.010. Epub 2016 Jul 7. Cancer Treat Rev. 2016. PMID: 27428850 Review.
-
Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation.Arch Gynecol Obstet. 2018 Jan;297(1):241-255. doi: 10.1007/s00404-017-4594-3. Epub 2017 Nov 24. Arch Gynecol Obstet. 2018. PMID: 29177593 Free PMC article.
Cited by
-
Integration of partners of young women with cancer in oncofertility evidence-based informational resources.Cancer Med. 2020 Oct;9(20):7375-7380. doi: 10.1002/cam4.3377. Epub 2020 Aug 30. Cancer Med. 2020. PMID: 32864852 Free PMC article. Review.
-
Oncofertility in Canada: the impact of cancer on fertility.Curr Oncol. 2013 Aug;20(4):e338-44. doi: 10.3747/co.20.1358. Curr Oncol. 2013. PMID: 23904772 Free PMC article.
-
Follicle development and its prediction in patients with primary ovarian insufficiency: Possible treatments and markers to maximize the ability to conceive with residual follicles.Reprod Med Biol. 2023 Dec 22;22(1):e12556. doi: 10.1002/rmb2.12556. eCollection 2023 Jan-Dec. Reprod Med Biol. 2023. PMID: 38144239 Free PMC article. Review.
-
Practices, Attitudes, and Knowledge Among Healthcare Providers and Oncologists in China Regarding Male Fertility Preservation.Front Reprod Health. 2022 Jan 31;4:801378. doi: 10.3389/frph.2022.801378. eCollection 2022. Front Reprod Health. 2022. PMID: 36303632 Free PMC article.
-
The role of menstrual cycle phase and AMH levels in breast cancer patients whose ovarian tissue was cryopreserved for oncofertility treatment.J Assist Reprod Genet. 2015 Feb;32(2):305-12. doi: 10.1007/s10815-014-0392-z. Epub 2014 Dec 3. J Assist Reprod Genet. 2015. PMID: 25464895 Free PMC article.
References
-
- Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K, American Society of Clinical Oncology American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–2931. doi: 10.1200/JCO.2006.06.5888. - DOI - PubMed
-
- FertiPROTEKT. Website of the “Network for fertility preservation before chemo and radiotherapy”, http://www.fertiprotekt.eu. Responsible: Prof. Dr. Michael von Wolff. Installed 01’ 2007, Last update 03’ 2009
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical